S J M Weatherby, N C Edwards, R West, M T E Heafield. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » AdultFemaleFibrinolytic Agents/administration & dosageFibrinolytic Agents/therapeutic useHeparin/administration & dosageHeparin/therapeutic useHumansInfusions, IntravenousPregnancyPregnancy Complications, Cardiovascular/drug therapyPregnancy Complications, Cardiovascular/physiopathologySagittal Sinus Thrombosis/drug therapySagittal Sinus Thrombosis/physiopathologyThrombolytic TherapyTissue Plasminogen Activator/administration & dosageTissue Plasminogen Activator/therapeutic use
Substances: See more » Fibrinolytic AgentsHeparinTissue Plasminogen Activator
Year: 2003 PMID: 14648156 DOI: 10.1007/s00415-003-0173-6
Source DB: PubMed Journal: J Neurol ISSN: 0340-5354 Impact factor: 4.849